Novo Nordisk has announced the appointment of Michala Fischer-Hansen as Managing Director of its business in Australia and New Zealand.
Michala succeeds Peter Soelberg, who was recently promoted to Corporate Vice President, International Operations, based in Turkey.
Michala comes to Australia after a long and successful career with the Danish-based Novo Nordisk, having joined the company's global marketing organisation in 2000 and worked in a number of positions of increasing seniority within pricing, brand management and communication.
She most recently worked in the company's global headquarters as Corporate Vice President responsible for the commercialisation and life cycle management of its new insulin portfolio globally.